Polymyxin B: similarities to and differences from colistin (polymyxin E). - Wikidata - awgldk - TriplyDB

Polymyxin B: similarities to and differences from colistin (polymyxin E).

Polymyxin B: similarities to and differences from colistin (polymyxin E).

http://www.wikidata.org/entity/Q36960059

about

Effective antibiotics in combination against extreme drug-resistant Pseudomonas aeruginosa with decreased susceptibility to polymyxin B Polymyxin B, in combination with fluconazole, exerts a potent fungicidal effect.In vitro antimicrobial activity and mutant prevention concentration of colistin against Acinetobacter baumannii.The role of antimicrobial peptides in preventing multidrug-resistant bacterial infections and biofilm formation.Examination of bacterial inhibition using a catalytic DNA Serotypes and antimicrobial susceptibility of Salmonella spp. isolated from farm animals in China.Disruption of Membrane by Colistin Kills Uropathogenic Escherichia coli Persisters and Enhances Killing of Other Antibiotics Pharmacokinetics and efficacy of liposomal polymyxin B in a murine pneumonia model.In vitro assessment and multicenter cohort study of comparative nephrotoxicity rates associated with colistimethate versus polymyxin B therapy.Multidrug-resistant Gram-negative infections: the use of colistin.The potential of antimicrobial peptides as biocides.Colistin: an update on the antibiotic of the 21st century.To B or not to B, that is the question: is it time to replace colistin with polymyxin B?Lipopeptides: from self-assembly to bioactivity.Therapeutic cyclic lipopeptides mining from microbes: latest strides and hurdles.Polymyxin B versus colistin: an update.Aerosolized Polymyxin B for Treatment of Respiratory Tract Infections: Determination of Pharmacokinetic-Pharmacodynamic Indices for Aerosolized Polymyxin B against Pseudomonas aeruginosa in a Mouse Lung Infection Model.Ten years with colistin: a retrospective case series.Electrostatically entrapped colistin liposomes for the treatment of Pseudomonas aeruginosa infection.Preparation and characterisation of the colistin-entrapped liposome driven by electrostatic interaction for intravenous administration.Bio-Inspired Coating Strategies for the Immobilization of Polymyxins to Generate Contact-Killing Surfaces.Effectiveness of antibacterial prophylaxis with non-absorbable polymyxin B compared to levofloxacin after allogeneic hematopoietic stem cell transplantation.Thermodynamics of RTA3 peptide binding to membranes and consequences for antimicrobial activity.Factor H-binding protein is important for meningococcal survival in human whole blood and serum and in the presence of the antimicrobial peptide LL-37.In vitro evaluation of antibiotic synergy for polymyxin B-resistant carbapenemase-producing Klebsiella pneumoniae Antimicrobial peptides for gram-negative sepsis: a case for the polymyxins.Combination therapy with polymyxin B and netropsin against clinical isolates of multidrug-resistant Acinetobacter baumannii.Pharmacokinetics of polymyxin B in a patient with renal insufficiency: a case report Prevalence and risk factors for acute kidney injury associated with parenteral polymyxin B use.The impact of polymyxin B dosage on in-hospital mortality of patients treated with this antibiotic.Parenteral polymyxin B use in patients with multidrug-resistant gram-negative bacteremia and urinary tract infections: a retrospective case series.Higher incidence of acute kidney injury with intravenous colistimethate sodium compared with polymyxin B in critically ill patients at a tertiary care medical center.Minocycline attenuates colistin-induced neurotoxicity via suppression of apoptosis, mitochondrial dysfunction and oxidative stress.Pterostilbene, a potential MCR-1 inhibitor that enhances the efficacy of polymyxin B.Efficacy of systemically administered polymyxins in mouse burn wound infection caused by multidrug-resistant Gram-negative pathogens: A proof-of-concept study.Polymyxin B in Combination with Enrofloxacin Exerts Synergistic Killing against Extensive Drug-resistant Pseudomonas aeruginosa.Modulation of Haemophilus influenzae interaction with hydrophobic molecules by the VacJ/MlaA lipoprotein impacts strongly on its interplay with the airways.

P2860

Q28478261-02C35398-5747-47A8-B3F4-EE4B742245E6 Q33532335-FD636B94-8DE5-4B0D-BB23-C4321B682C5A Q34108501-DBCE94FF-16A2-464B-BA13-921C5FA14D05 Q35297286-CE90A0E0-BF05-4305-B70F-B486DE359D70 Q35532061-DD913F6F-B4DD-4F8F-B142-949681802E3D Q35765615-C8EE1DD5-4AE8-43AB-AB7F-47F4D8F81848 Q37358713-2FBB28D4-616F-44BF-AF31-960DE0F7BC02 Q37360650-99B5281B-6F56-4757-B999-AF39DB0C2A22 Q37712983-304092A2-D04C-4777-B330-9C7C6CCE9DC2 Q37785545-C68A6704-E970-46F6-BDC5-713142C8BFC5 Q37954604-3767ABB2-0333-43C7-919B-241E5E022C3F Q38048852-D4CA5926-D722-4D65-B34B-4339B043E9D0 Q38262873-5B681DA9-1B8C-4C45-AA83-23FD0D41DB4C Q38387028-2CFA8C03-E065-4A5B-B386-E6419CC7A99F Q38515064-44B53925-0B50-474C-986C-51427647AE32 Q38613051-6E7F983A-EC87-4E60-9D21-8B89A047665E Q38755683-FACD4C1C-ACD0-469B-B497-026E3352E32C Q39690212-2615FEDC-5391-49BE-B021-56BAE15F5F7A Q40558076-3335A23F-8B9C-406C-8B83-B6AE3CF1ACE6 Q40621875-B7F9240C-1402-43BE-9D69-04CFFA6E39B2 Q40636333-974BCCF5-5BA8-4886-9223-FB8275495F06 Q40776609-7A1A8F85-D8EF-430B-BB61-A59C4BAB09EE Q40791392-E13E1D2C-84D0-403D-8303-1193CC7454C5 Q41825787-CEC1D38F-BE35-4156-8EB0-669E22BDD48D Q41827843-4ABB832F-B1DD-400E-9D72-47D32182E791 Q42276631-80774074-ECF9-442F-B90B-83EA162A1A1E Q42701999-BE3B0974-2E3A-4EA1-B718-FF095D638D3C Q42757854-BE9B1E1B-89A2-4F05-B5D3-DE903714C843 Q43249112-9867C103-6810-404E-B7E9-A34FAC319603 Q43438799-8A9B236E-2BAB-4EC4-A5EA-8DC454CF1B8B Q43870052-D469FF16-CAE8-477B-9EBE-AA7F85BC72D1 Q46016195-45CBDD47-78F4-4A7B-9510-B238556C2F66 Q46417226-CA923986-2DB7-4E5F-85BB-1FD5290A03FC Q50020741-78EF6FD3-C9A7-471F-932F-A24F95D32421 Q50028112-3C4CAD5B-28E8-4AC4-8F7C-F6D54ADE9DE6 Q52597958-11904DCB-1D28-4166-BC18-C06E88830115 Q55347367-D4F5E270-DC2B-4225-B5DB-4D1BEFC1B88C

P2860

Polymyxin B: similarities to and differences from colistin (polymyxin E).

http://www.wikidata.org/entity/Q36960059

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Polymyxin B: similarities to and differences from colistin (polymyxin E).

@en

type

label

Polymyxin B: similarities to and differences from colistin (polymyxin E).

@en

prefLabel

Polymyxin B: similarities to and differences from colistin (polymyxin E).

@en

P1433

Q36960059-2F323508-D782-4AA2-AF5D-1230EAADE6C2

P1476

Q36960059-B4FF4716-3653-476E-BFE5-3A5A6CD0DFDA

P2093

Q36960059-3BA3A5C0-F8EB-4084-B40D-BAD8B0D62B7E

Q36960059-7E19B045-6EF1-494F-A82D-84C7151370FD

Q36960059-D9D2E5AD-E4AC-4490-B1C2-79253FE5EF76

P2860

Q36960059-0337D632-5E1A-4F01-A08A-6ED3B147AEAB

Q36960059-044EC0B2-23A7-41C3-906C-654774831C91

Q36960059-0646C001-67A0-41C9-8E50-DA949315A3F2

Q36960059-1A9EF867-8ADF-47C6-A5C6-4B2A4BDA9C10

Q36960059-1C469D68-AC24-49A5-87AB-58EC23E5B1C9

Q36960059-1D210623-62CB-4C98-92B7-BD0522A1EFA0

Q36960059-2036C999-4B81-4E5B-9D50-9CEA5BCBE1FD

Q36960059-2E89F097-182C-4A85-9BA0-8B0063996A0C

Q36960059-334158F3-EB28-4F9C-BB1E-71D1EAE823B6

Q36960059-3B9B45B2-EF35-4C9E-A20E-04D05B490A6F

P304

Q36960059-CF416D65-AF9B-4782-A91D-4E95C54E34E6

P31

Q36960059-A767784C-32D9-4FCF-8036-A2B6D8616D4C

P356

Q36960059-3828D8AA-34E0-4753-BCC3-042F5CDAE49C

P433

Q36960059-0CB07167-0B8E-479C-886F-29C846A036AC

P478

Q36960059-B3AE57E7-7FF0-4C65-8F5E-5106387705ED

P50

Q36960059-FFAFF3BC-9D0C-4941-88B9-0E54FE6EDB72

P577

Q36960059-2FD3221C-65EF-43A6-9134-4627F0653416

P5875

Q36960059-D394A83D-C063-44E1-B9DC-C4079BA91B72

P698

Q36960059-D6B33BE2-30CC-4D30-AA03-C192D956FCE2

P356

14787210.5.5.811

P1433

Expert Review of Anti-infective Therapy

P1476

Polymyxin B: similarities to and differences from colistin (polymyxin E).

@en

P2093

Andrea Kwa

http://www.w3.org/2001/XMLSchema#string

Sofia K Kasiakou

http://www.w3.org/2001/XMLSchema#string

Vincent H Tam

http://www.w3.org/2001/XMLSchema#string

P2860

Toxicity of polymyxins: a systematic review of the evidence from old and recent studies

Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients

Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria

Toxicity after prolonged (more than four weeks) administration of intravenous colistin

Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature review

Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria.

Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa.

Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.

Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate.

Practice guidelines for the management of bacterial meningitis.

P304

811-821

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14787210.5.5.811

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Matthew E. Falagas

P577

2007-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5929926

http://www.w3.org/2001/XMLSchema#string

P698

17914915

http://www.w3.org/2001/XMLSchema#string